Study guide
4.2 Culture Media Classification, Quality Control, and Inoculation Techniques
Philippine Medical Technologists Licensure Examination MTLE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Clinical Chemistry: Laboratory Operations, Instrumentation, Reagents, Quality Assurance, and Safety
1.1 Specimen Collection, Preanalytical Variables, and Interferences 1.2 Clinical Chemistry Instrumentation, Photometry, and Automation 1.3 Quality Control, Westgard Rules, Calibration, and Laboratory Mathematics 1.4 Reagent Preparation, Laboratory Water, Glassware, Pipettes, and Centrifuges 1.5 Laboratory Safety: Chemical, Fire, Electrical, Biological, and Physical Hazards
2 Chapter 2: Clinical Chemistry: Carbohydrates, Lipids, Proteins, Non-Protein Nitrogen, and Liver Function
2.1 Glucose Homeostasis, Diagnostic Criteria for Diabetes Mellitus, and Glycemic Monitoring 2.2 Lipids, Lipoproteins, Apolipoproteins, and Coronary Heart Disease Risk Assessment 2.3 Serum Proteins, Albumin, Globulins, and Serum Protein Electrophoresis Patterns 2.4 Non-Protein Nitrogen Compounds: Urea, Creatinine, Uric Acid, and Renal Function 2.5 Liver Function Tests, Bilirubin Metabolism, and Jaundice
3 Chapter 3: Clinical Chemistry: Electrolytes, Blood Gases, Enzymology, Endocrinology, and Toxicology
3.1 Water Balance, Electrolytes, Osmolality, and Anion Gap Calculations 3.2 Blood Gas Analysis, Oxygenation, and Acid-Base Homeostasis 3.3 Clinical Enzymology: Enzyme Kinetics, Cardiac Biomarkers, and Hepatic and Pancreatic Enzymes 3.4 Endocrinology: Hormone Physiology and Endocrine Function Testing 3.5 Therapeutic Drug Monitoring and Clinical Toxicology
4 Chapter 4: Bacteriology: Specimen Management, Media, Staining, and Biosafety
4.1 Specimen Collection, Transport, Processing, and Microscopic Staining 4.2 Culture Media Classification, Quality Control, and Inoculation Techniques 4.3 Sterilization, Disinfection, Decontamination, and Biosafety Containment 4.4 Antimicrobial Susceptibility Testing Methods, Standardization, and Resistance Mechanisms
5 Chapter 5: Diagnostic Bacteriology: Major Pathogenic Bacteria
5.1 Medically Important Gram-Positive Cocci: Staphylococci, Streptococci, and Enterococci 5.2 Medically Important Gram-Negative Bacilli: Enterobacterales and Non-Fermenters 5.3 Fastidious, Microaerophilic, and Anaerobic Bacteria 5.4 Mycobacteria, Spirochetes, Atypical Bacteria, and Public Health Microbiology
6 Chapter 6: Medical Parasitology, Mycology, and Diagnostic Virology
6.1 Stool Examination Techniques and Intestinal Nematodes 6.2 Tissue Nematodes, Filarial Worms, Cestodes, and Trematodes 6.3 Medical Protozoology: Intestinal, Urogenital, and Blood/Tissue Protozoa 6.4 Medical Mycology: Yeasts, Dermatophytes, Dimorphic Fungi, and Opportunistic Molds 6.5 Clinical Virology: Viral Structure, Specimen Handling, and Diagnostic Methods
7 Chapter 7: Hematology: Specimen Collection, Routine Parameters, Instrumentation, and Manual Methods
7.1 Blood Specimen Collection, Anticoagulants, Preanalytical Variables, and Specimen Quality 7.2 Automated Cell Counting Principles, Complete Blood Count Parameters, and Erythrocyte Indices 7.3 Reticulocyte Evaluation, Supravital Staining, and Erythrocyte Sedimentation Rate 7.4 Manual Cell Counts, Manual Hemoglobin Methods, and Hematology Quality Control
8 Chapter 8: Hematology: Blood Cell Morphology, Bone Marrow, and Hematologic Disorders
8.1 Normal Erythropoiesis and Erythrocyte Morphologic Abnormalities 8.2 Anemias: Classification, Iron Deficiency, Megaloblastic, Hemolytic, and Hemoglobinopathies 8.3 Normal Leukopoiesis, Leukocyte Differential, and Non-Malignant White Cell Alterations 8.4 Hematologic Malignancies: Acute and Chronic Leukemias, Myeloproliferative and Lymphoproliferative Disorders 8.5 Peripheral Blood Smear Preparation and Staining, Bone Marrow Examination, and Cytochemistry
9 Chapter 9: Hemostasis: Coagulation and Platelet Function Testing and Hemostatic Disorders
9.1 Mechanisms of Primary and Secondary Hemostasis, Fibrinolysis, and Natural Inhibitors 9.2 Coagulation Laboratory Testing: PT/INR, aPTT, Fibrinogen, Thrombin Time, and Mixing Studies 9.3 Hemostatic and Thrombotic Disorders: Hemophilias, von Willebrand Disease, DIC, and Thrombophilias 9.4 Bleeding Time, Clotting Time, Platelet Function, and Special Hematology Tests
10 Chapter 10: Immunohematology: Blood Group Systems and Antiglobulin Testing
10.1 The ABO Blood Group System, Genetics, Subgroups, and Forward/Reverse Typing Discrepancies 10.2 The Rh Blood Group System, Weak D Testing, and Other Major Blood Group Systems 10.3 Antiglobulin Testing, Elution, Adsorption, and Special Antibody Procedures
11 Chapter 11: Blood Banking: Donor Operations, Component Therapy, and Adverse Reactions
11.1 Donor Selection, Physical Examination, Screening, and Mandatory Infectious Marker Testing 11.2 Blood Component Preparation, Storage, Expiration, and Indications for Transfusion 11.3 Pre-Transfusion Compatibility Testing and Transfusion Reactions 11.4 Hemolytic Disease of the Fetus and Newborn (HDFN) and Rh Immune Globulin
12 Chapter 12: Clinical Serology and Immunology
12.1 Principles of Immunology: Antigens, Antibodies, Complement, and Immune Responses 12.2 Serologic Testing Methodologies: Agglutination, Precipitation, Flocculation, and Labeled Immunoassays 12.3 Infectious Disease Serology: Syphilis, Viral Hepatitis Markers, HIV, Dengue, and Febrile Agglutinins 12.4 Autoimmune Serology, Hypersensitivity, Immunodeficiencies, and Histocompatibility (HLA)
13 Chapter 13: Clinical Microscopy: Urinalysis and Renal Pathology
13.1 Renal Physiology, Urine Formation, and Physical Examination of Urine 13.2 Chemical Examination of Urine: Reagent Strip Principles, Interferences, and Confirmatory Tests 13.3 Microscopic Examination of Urine Sediment: Cells, Casts, Crystals, and Contaminants 13.4 Renal Calculi, Glomerular/Tubular/Interstitial Renal Diseases, and Urinalysis Quality Control
14 Chapter 14: Clinical Microscopy: Body Fluids, Fecal Analysis, and Gastric, Duodenal, and Respiratory Specimens
14.1 Cerebrospinal Fluid Analysis: Collection, Cell Counts, Chemistry, and Microbiology 14.2 Serous Fluids (Pleural, Pericardial, Peritoneal: Transudates vs Exudates) and Synovial Fluid Analysis 14.3 Seminal Fluid and Amniotic Fluid Analysis 14.4 Fecal Analysis: Macroscopic, Microscopic, and Chemical Examination of Stool 14.5 Gastric Fluid, Duodenal Contents, Sputum, and Bronchoalveolar Specimens
15 Chapter 15: Histopathologic Techniques and Cytotechnology
15.1 Tissue Preservation, Fixation, Decalcification, and Processing Steps 15.2 Microtomy, Sectioning Artifacts, Hematoxylin and Eosin Staining, and Special Stains 15.3 Cytotechnology: Specimen Collection, Fixation, Papanicolaou Staining, and the Bethesda System 15.4 Special Procedures: Frozen Sections, Special Embedding, Immunohistochemistry, Electron Microscopy, Autopsy, Museum Techniques, and Laboratory Records
16 Chapter 16: Medical Technology Laws, Related Laws, and Ethics
16.1 Republic Act No. 5527 (The Philippine Medical Technology Act of 1969) and Key Amendments 16.2 Related Philippine Healthcare Laws, Code of Ethics, and Bioethics
4.2 Culture Media Classification, Quality Control, and Inoculation Techniques
Key Takeaways Explain This Topic AI
Bacteriological culture media are categorized functionally as supportive, enriched, selective, differential, or enrichment broths to isolate pathogens from polymicrobial native flora.
Sheep Blood Agar assesses alpha, beta, and gamma hemolysis, whereas Chocolate Agar provides factor X (hemin) and factor V (NAD) required for fastidious Haemophilus and Neisseria species.
Quantitative urine culture utilizes calibrated loops ( 0.001 mL 0.001\text{ mL} 0.001 mL or 0.01 mL 0.01\text{ mL} 0.01 mL ), where a single-pathogen colony count of ≥ 100 , 000 CFU/mL \ge 100,000\text{ CFU/mL} ≥ 100 , 000 CFU/mL ( ≥ 10 5 CFU/mL \ge 10^5\text{ CFU/mL} ≥ 1 0 5 CFU/mL ) defines clinically significant bacteriuria in clean-catch specimens.
Atmospheric incubation requirements dictate strict physiological gas mixtures: capnophiles require 5 % to 10 % C O 2 5\%\text{ to }10\%\text{ }CO_2 5% to 10% C O 2 , microaerophiles require 5 % O 2 5\%\text{ }O_2 5% O 2 and 10 % C O 2 10\%\text{ }CO_2 10% C O 2 , and strict anaerobes require an oxygen-free environment monitored by methylene blue or resazurin redox indicators.
Last updated: October 2026
Culture Media Classification, Quality Control, and Inoculation Techniques
The cultivation and phenotypic isolation of bacterial pathogens from clinical specimens require specialized artificial nutrient matrices that replicate in vivo physiological conditions. Because clinical specimens frequently contain a mixture of host tissues, normal commensal flora, and potential pathogens, the medical technologist must select media formulations that provide growth factors for fastidious pathogens while suppressing contaminating flora. For the MTLE, mastering media classifications, biochemical indicator reactions, loop calibration arithmetic, and incubation parameters is essential.
1. Functional Classifications and Formulations of Culture Media
Culture media are classified based on their nutritional composition and functional diagnostic purpose:
Supportive (Nutrient) Media
Supportive media contain basic nutrients (peptones, meat extract, sodium chloride) that sustain the growth of non-fastidious bacterial species without conferring a growth advantage to any particular group. Examples include Nutrient Agar and Trypticase Soy Agar (TSA) .
Enriched Media
Enriched media are supplemented with complex organic nutrients—such as defibrinated whole blood, lysed erythrocytes, serum, vitamins, or yeast extract—to cultivate fastidious organisms:
Sheep Blood Agar (SBA / BAP) : Formulated with a nutrient base (TSA or Columbia agar) supplemented with 5 % 5\% 5% defibrinated sheep red blood cells (RBCs) . SBA is both enriched and differential, allowing preliminary identification based on hemolytic patterns:
Alpha ( α \alpha α ) Hemolysis : Partial, incomplete lysis of red blood cells producing a hazy, greenish-brown discoloration surrounding the colonies. The green hue is caused by bacterial production of hydrogen peroxide ( H 2 O 2 H_2O_2 H 2 O 2 ), which oxidizes red hemoglobin into brown biliverdin and methemoglobin ( Streptococcus pneumoniae , viridans group streptococci).
Beta ( β \beta β ) Hemolysis : Complete enzymatic lysis and clearing of erythrocytes, creating a transparent, clear halo around the colony. Mediated by extracellular pore-forming hemolysins: streptolysin O (oxygen-labile) and streptolysin S (oxygen-stable) in Streptococcus pyogenes (Group A Strep), the β-hemolysin/cytolysin of Streptococcus agalactiae (Group B Strep, which gives a narrow zone), or α \alpha α -toxin in Staphylococcus aureus .
Gamma ( γ \gamma γ ) Hemolysis : Complete absence of erythrocyte lysis; no color change or clearing occurs around colonies ( Enterococcus faecalis ).
Why Sheep Blood? Defibrinated sheep blood is standard because human blood may contain citrate preservatives, isoantibodies, or residual antibiotics that inhibit bacterial growth. Furthermore, sheep blood does not support the growth of Haemophilus haemolyticus , an upper respiratory commensal whose β \beta β -hemolysis on horse or rabbit blood can be mistakenly identified as S. pyogenes .
Chocolate Agar (CAP) : Prepared by adding 5 % 5\% 5% defibrinated sheep blood to molten nutrient base at 80 ∘ C 80^\circ\text{C} 8 0 ∘ C . Gentle heating lyses the red cells, turning the medium a rich brown color. Heat releases intracellular Factor X (hemin/hematin) and Factor V (Nicotinamide Adenine Dinucleotide, NAD) into the agar matrix while simultaneously destroying endogenous erythrocyte NADase enzymes that would otherwise degrade Factor V. Chocolate agar is required for cultivating fastidious species: Haemophilus influenzae (which requires both X and V factors), Haemophilus parainfluenzae (requires V factor only), and Neisseria gonorrhoeae .
Selective and Differential Media for Gram-Negative Bacilli
MacConkey (MAC) Agar :
Selective Components : Bile salts and crystal violet inhibit the growth of Gram-positive organisms.
Differential Carbohydrate : Lactose ( 1 % 1\% 1% ) .
pH Indicator : Neutral red (red/pink at acidic pH < 6.8 \text{pH} < 6.8 pH < 6.8 ; colorless at neutral/alkaline pH > 6.8 \text{pH} > 6.8 pH > 6.8 ).
Reaction Mechanisms : Lactose fermenters ( Escherichia coli , Klebsiella pneumoniae , Enterobacter ) metabolize lactose into mixed organic acids, lowering the pH. This turns neutral red to a bright pink/red color and causes bile salts to precipitate as a hazy pink halo around the colonies. Non-lactose fermenters ( Pseudomonas aeruginosa , Proteus mirabilis , Salmonella , Shigella ) utilize peptones, releasing alkaline amine byproducts that raise pH, producing colorless, translucent colonies.
Eosin Methylene Blue (EMB) Agar :
Selective Components : Eosin Y and methylene blue dyes inhibit Gram-positive organisms.
Differential Carbohydrate : Lactose and sucrose.
Reaction Mechanisms : Vigorous lactose fermenters like Escherichia coli generate high acid levels that precipitate methylene blue-eosin dye complexes, producing colonies with a distinctive dark center and green metallic sheen . Weaker or slower fermenters ( Klebsiella , Enterobacter ) produce pink-to-purple mucoid colonies without a sheen. Non-fermenters appear translucent or amber.
Hektoen Enteric (HE) Agar :
Selective Components : High concentration of bile salts inhibits Gram-positives and suppresses non-pathogenic coliforms.
Differential Carbohydrates : Lactose, sucrose, and salicin.
Indicators : Bromthymol blue and acid fuchsin (yellow/orange in acid).
Hydrogen Sulfide ( H 2 S H_2S H 2 S ) System : Sodium thiosulfate (sulfur source) and ferric ammonium citrate (iron indicator).
Reaction Mechanisms : Coliforms ferment carbohydrates into acid, forming bright yellow-to-orange colonies. Non-fermenters: Shigella species appear green-to-blue-green without black centers. Salmonella species do not ferment the sugars (retaining a green-blue base) but reduce thiosulfate to H 2 S H_2S H 2 S , which reacts with ferric ammonium citrate to precipitate insoluble black ferric sulfide ( F e S FeS F e S ), producing blue-green colonies with black centers .
Xylose Lysine Deoxycholate (XLD) Agar :
Selective Component : Sodium deoxycholate ( 0.25 % 0.25\% 0.25% ) inhibits Gram-positives.
Differential Components : Xylose, L-lysine, lactose, sucrose, and phenol red indicator (yellow in acid, red in alkali), with sodium thiosulfate and ferric ammonium citrate.
Reaction Mechanisms : Salmonella ferments xylose initially (turning yellow), but upon xylose depletion, decarboxylates L-lysine via lysine decarboxylase into cadaverine, reverting the local pH to alkaline red. Concurrently, it produces H 2 S H_2S H 2 S , forming red colonies with black centers . Shigella lacks xylose fermentation and lysine decarboxylation, growing as translucent red colonies . Coliforms ferment excess lactose and sucrose, remaining persistently yellow.
Thiosulfate Citrate Bile Salts Sucrose (TCBS) Agar :
Selective Components : Elevated alkaline pH of 8.6 \text{pH of } 8.6 pH of 8.6 , oxgall/bile salts, and sodium citrate strongly suppress enterobacteria and Gram-positives.
Differential Carbohydrate : Sucrose ( 2 % 2\% 2% ) with bromthymol blue and thymol blue indicators.
Reaction Mechanisms : Vibrio cholerae and Vibrio alginolyticus ferment sucrose, lowering the pH to produce bright yellow colonies . Non-sucrose fermenters—such as Vibrio parahaemolyticus and Vibrio vulnificus —form blue-green colonies .
Selective Media for Gram-Positive Cocci and Fastidious Pathogens
Phenylethyl Alcohol (PEA) Agar : Sheep blood agar base containing 0.25 % 0.25\% 0.25% phenylethyl alcohol. Phenylethyl alcohol disrupts Gram-negative bacterial outer lipopolysaccharide membranes and interferes with DNA synthesis, selectively isolating Gram-positive cocci ( Staphylococcus , Streptococcus , Enterococcus ) from specimens heavily contaminated with swarming Proteus .
Colistin-Nalidixic Acid (CNA) Agar : Columbia blood agar containing colistin (disrupts Gram-negative outer cell membranes) and nalidixic acid (inhibits Gram-negative DNA gyrase), isolating Gram-positive cocci while suppressing Gram-negative enteric bacilli.
Thayer-Martin (TM) and Modified Thayer-Martin (MTM) Agar : Chocolate agar base enriched with four selective antimicrobials to isolate Neisseria gonorrhoeae and Neisseria meningitidis from polymicrobial urogenital and pharyngeal sites:
Vancomycin ( 3 μ g/mL 3\ \mu\text{g/mL} 3 μ g/mL ) : Inhibits Gram-positive bacteria.
Colistin ( 7.5 μ g/mL 7.5\ \mu\text{g/mL} 7.5 μ g/mL ) : Inhibits Gram-negative bacilli, sparing Neisseria .
Nystatin ( 12.5 units/mL 12.5\text{ units/mL} 12.5 units/mL ) : Inhibits yeasts ( Candida albicans ).
Trimethoprim lactate ( 5 μ g/mL 5\ \mu\text{g/mL} 5 μ g/mL ) : Inhibits the swarming of Proteus species.
Formulation Variants : Martin-Lewis (ML) agar substitutes anisomycin for nystatin to extend shelf-life; New York City (NYC) medium uses a clear starch-cornstarch base with amphotericin B and supports the recovery of Mycoplasma hominis and Ureaplasma urealyticum .
Enrichment Liquid Broths
Thioglycollate Broth : Enriched multipurpose broth containing pancreatic digest of casein, glucose, yeast extract, sodium thioglycollate, L-cystine, and 0.075 % 0.075\% 0.075% agar . Sodium thioglycollate and cystine serve as reducing agents, while low-concentration agar prevents convective mixing, creating an oxygen gradient along the vertical tube depth:
Surface (Oxidized Zone) : Dissolved oxygen present; resazurin indicator turns pink.
Depths (Reduced Zone) : Anaerobic environment; resazurin remains colorless.
Growth Stratification : Strict aerobes ( Pseudomonas aeruginosa ) grow exclusively at the top meniscus; facultative anaerobes ( Staphylococcus , E. coli ) grow diffusely throughout; strict obligate anaerobes ( Clostridium ) grow strictly at the bottom; microaerophiles grow in a narrow layer just beneath the surface.
Selenite F and Tetrathionate Broths : Selective enrichment broths for feces. Sodium selenite or tetrathionate inhibits the replication of normal coliforms during the initial 12 to 18 hours 12\text{ to }18\text{ hours} 12 to 18 hours of incubation, permitting small quantities of Salmonella and Shigella to multiply before subculturing onto selective differential plating media.
2. Inoculation Techniques and Quantitative Urine Cultures ┌────────────────────────────────────────────────────────┐
- │ Quantitative Urine Culture Protocol │
- └───────────────────────────┬────────────────────────────┘
- │
- ┌──────────────────────────────────┴──────────────────────────────────┐
- ▼ ▼
- ┌──────────────────────┐ ┌──────────────────────┐
- │ 0.001 mL (1 µL) Loop │ │ 0.01 mL (10 µL) Loop │
- │ Multiplier: x 1,000 │ │ Multiplier: x 100 │
- └──────────┬───────────┘ └──────────┬───────────┘
- │ │
- Standard for clean-catch Standard for catheterized,
- midstream urine collections infants, or suprapubic taps
- │ │
- ├───────────────────────────────────┬─────────────────────────────────┤
- ▼ ▼ ▼
- ≥100 Colonies 10-99 Colonies <10 Colonies
- (≥100,000 CFU/mL) (10,000-99,000 CFU/mL) (<10,000 CFU/mL)
- │ │ │
- Definitive Bacteriuria Probable UTI if symptomatic Probable Contamination
- (Proceed to ID and AST) with pyuria; pure isolate (Unless suprapubic tap)
- Quantitative Urine Inoculation Principles
Clean-catch midstream urine specimens pass through the distal urethra, picking up normal skin and mucosal colonizers ( Corynebacterium , CoNS, lactobacilli). Quantitation distinguishes genuine infection from contamination:
Calibrated Wire or Plastic Loops :
0.001 mL 0.001\text{ mL} 0.001 mL ( 1 μ L 1\ \mu\text{L} 1 μ L ) Loop : Delivers a volume of 1 / 1 , 000 mL 1/1,000\text{ mL} 1/1 , 000 mL . Each colony that grows on the agar plate represents 1 , 000 colony-forming units per milliliter (CFU/mL) 1,000\text{ colony-forming units per milliliter (CFU/mL)} 1 , 000 colony-forming units per milliliter (CFU/mL) . CFU/mL = Number of Colonies × 1 , 000 \text{CFU/mL} = \text{Number of Colonies} \times 1,000 CFU/mL = Number of Colonies × 1 , 000 Example : 85 colonies on an SBA plate inoculated with a 0.001 mL 0.001\text{ mL} 0.001 mL loop = 85 × 1 , 000 = 85 , 000 CFU/mL = 85 \times 1,000 = 85,000\text{ CFU/mL} = 85 × 1 , 000 = 85 , 000 CFU/mL .
0.01 mL 0.01\text{ mL} 0.01 mL ( 10 μ L 10\ \mu\text{L} 10 μ L ) Loop : Delivers a volume of 1 / 100 mL 1/100\text{ mL} 1/100 mL . Each colony represents 100 CFU/mL 100\text{ CFU/mL} 100 CFU/mL . CFU/mL = Number of Colonies × 100 \text{CFU/mL} = \text{Number of Colonies} \times 100 CFU/mL = Number of Colonies × 100 Used for low colony count expectations: straight catheterizations, pediatric collection bags, and suprapubic aspirates.
Clinical Diagnostic Thresholds :
Clean-Catch Midstream Urine : ≥ 100 , 000 CFU/mL \mathbf{\ge 100,000\text{ CFU/mL}} ≥ 100 , 000 CFU/mL ( ≥ 10 5 CFU/mL \ge 10^5\text{ CFU/mL} ≥ 1 0 5 CFU/mL ) of a single uropathogen indicates definitive significant bacteriuria. In acute uncomplicated cystitis in females with pyuria, ≥ 10 , 000 CFU/mL \ge 10,000\text{ CFU/mL} ≥ 10 , 000 CFU/mL of a predominant pathogen ( E. coli , Staphylococcus saprophyticus ) is clinically actionable.
Catheterized Urine : ≥ 1 , 000 to 10 , 000 CFU/mL \ge 1,000\text{ to }10,000\text{ CFU/mL} ≥ 1 , 000 to 10 , 000 CFU/mL indicates catheter-associated UTI.
Suprapubic Bladder Aspiration : Because needle aspiration bypasses the urethra entirely, any colony growth ( > 100 CFU/mL >100\text{ CFU/mL} > 100 CFU/mL ) of a pathogen represents true bladder bacteriuria.
Polymicrobial Contamination : If ≥ 3 \ge 3 ≥ 3 distinct colony morphotypes are isolated from a clean-catch urine specimen, the culture represents periurethral and vaginal contamination and must be rejected with a request for re-collection.
3. Media Quality Control Standards (CLSI M22-A3)
Clinical laboratories must ensure culture media sterility and functional performance before patient testing:
Sterility Check : For in-house prepared media, 3 % to 5 % 3\%\text{ to }5\% 3% to 5% of each batch or lot is incubated uninoculated at 35 ∘ C 35^\circ\text{C} 3 5 ∘ C for 24 to 48 hours 24\text{ to }48\text{ hours} 24 to 48 hours to verify freedom from contamination.
Performance Quality Control Using ATCC Reference Strains :
MacConkey Agar : Tested with Escherichia coli ATCC 25922 (growth, pink lactose-fermenting colonies), Proteus mirabilis ATCC 12453 (growth, colorless colonies, swarming inhibited), and Staphylococcus aureus ATCC 25923 (complete growth inhibition).
Sheep Blood Agar : Tested with Streptococcus pyogenes ATCC 19615 (growth, distinct β \beta β -hemolysis) and Streptococcus pneumoniae ATCC 49619 (growth, α \alpha α -hemolysis).
Chocolate / Thayer-Martin : Tested with Neisseria gonorrhoeae ATCC 43069 (growth) and Neisseria sicca / S. epidermidis (inhibited on Thayer-Martin).
Exempt vs. Non-Exempt Media : Under CLSI document M22-A3, commercial media manufactured under accredited quality systems are exempt from user re-testing, EXCEPT for high-failure fastidious media that must always undergo user QC: Chocolate agar, Thayer-Martin / Martin-Lewis agars, and Campylobacter blood agars.
4. Atmospheric Incubation Parameters
Pathogenic bacteria exhibit diverse atmospheric requirements that must be controlled during incubation:
Atmospheric Condition Gas Composition Generation Method Representative Pathogens
Ambient Air 21 % O 2 21\%\ O_2 21% O 2 , 0.03 % C O 2 0.03\%\ CO_2 0.03% C O 2 , 78 % N 2 78\%\ N_2 78% N 2 Standard incubator at 35 ± 2 ∘ C 35\pm 2^\circ\text{C} 35 ± 2 ∘ C Staphylococcus , Enterobacterales, Pseudomonas
Capnophilic 5 % to 10 % C O 2 5\%\text{ to }10\%\ CO_2 5% to 10% C O 2 , 15 % to 18 % O 2 15\%\text{ to }18\%\ O_2 15% to 18% O 2 C O 2 CO_2 C O 2 incubator or candle extinction jar ( 3 % – 5 % C O 2 3\%\text{--}5\%\ CO_2 3% – 5% C O 2 ) Streptococcus pneumoniae , Neisseria gonorrhoeae , Haemophilus influenzae
Microaerophilic 5 % O 2 5\%\ O_2 5% O 2 , 10 % C O 2 10\%\ CO_2 10% C O 2 , 85 % N 2 85\%\ N_2 85% N 2 Gas-generating sachet in sealed jar; evacuation-replacement system Campylobacter jejuni (incubated at 42 ∘ C 42^\circ\text{C} 4 2 ∘ C ) , Helicobacter pylori ( 35 ∘ C 35^\circ\text{C} 3 5 ∘ C )
Anaerobic 85 % N 2 85\%\ N_2 85% N 2 , 10 % H 2 10\%\ H_2 10% H 2 , 5 % C O 2 5\%\ CO_2 5% C O 2 ( 0 % O 2 0\%\ O_2 0% O 2 ) Anaerobic jar / chamber with palladium catalyst: 2 H 2 + O 2 → Pd 2 H 2 O 2H_2 + O_2 \xrightarrow{\text{Pd}} 2H_2O 2 H 2 + O 2 Pd 2 H 2 O Clostridium perfringens , Bacteroides fragilis , Peptostreptococcus
Exam Key Point (Anaerobic Indicators) : Anaerobic jars contain chemical redox indicator strips to verify complete oxygen evacuation. Methylene blue strips are blue when exposed to oxygen (oxidized) and turn colorless (white) under reduced, anaerobic conditions. Resazurin strips are pink when oxidized and turn colorless (white) when reduced.